Efficacy of clindamycin phosphate and benzoyl peroxide gel (DUAC(®) ) in the treatment of EGFR inhibitors-associated acneiform eruption.
Department of Clinical and Experimental Medicine - Dermatology, University of Messina, Messina, Italy.
M
M
Vaccaro
Department of Clinical and Experimental Medicine - Dermatology, University of Messina, Messina, Italy.
F
F
Guarneri
Department of Clinical and Experimental Medicine - Dermatology, University of Messina, Messina, Italy.
F
F
Borgia
Department of Clinical and Experimental Medicine - Dermatology, University of Messina, Messina, Italy.|Medical Oncology Unit, Human Pathology Department, University of Messina, Messina, Italy.
A
A
Pollicino
Department of Clinical and Experimental Medicine - Dermatology, University of Messina, Messina, Italy.|Medical Oncology Unit, Human Pathology Department, University of Messina, Messina, Italy.
G
G
Altavilla
Department of Clinical and Experimental Medicine - Dermatology, University of Messina, Messina, Italy.
S P
SP
Cannavò
D017486:Acneiform Eruptions / Q000188:drug therapy*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001585:Benzoyl Peroxide / Q000008:administration & dosage / Q000627:therapeutic use*; D002981:Clindamycin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D066246:ErbB Receptors / Q000037:antagonists & inhibitors*; D005782:Gels; D006801:Humans; D008297:Male
D000900:Anti-Bacterial Agents; D005782:Gels; D002981:Clindamycin; D066246:ErbB Receptors; C007084:clindamycin phosphate; D001585:Benzoyl Peroxide